Harnessing the self-assembly of peptides for the targeted delivery of anti-cancer agents

Abstract

Self-assembling peptide hydrogels can effectively transport, hold and release therapeutic molecules in a spatially and temporally controlled manner and, in doing so, improve anti-cancer drug efficacy while reducing non-specific toxicity.